Central Bank & Trust’s Amdocs DOX Stock Holding History

Central Bank & Trust’s Portfolio DOX Stock Details DOX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	–	Sell	-550	Closed	-$43K	–	303
2021 Q2	$43K	Hold	550	–	–	0.01%	224
2021 Q1	$39K	Buy	+550	New	+$41.5K	0.01%	222

Other funds holding DOX

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Pzena Investment Management New York $30.8B AUM 11.29% 1-Year Est. Return

LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return

BGC

Beutel, Goodman & Co Toronto, Ontario, Canada $14.8B AUM 15.12% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Nordea Investment Management Stockholm, Sweden $107B AUM 24.58% 1-Year Est. Return

Fidelity International Hamilton, Bermuda $129B AUM 30.83% 1-Year Est. Return

Central Bank & Trust's DOX Position: Q3 2021 in Review

Central Bank & Trust sold out of Amdocs (DOX) in Q3 2021, closing a stake of 550 shares — an estimated $43K sold.

Central Bank & Trust first reported a position in DOX in Q1 2021 and held it in 2 quarters. The position peaked at $43K in Q2 2021. 411 funds tracked by Wall St. Rank hold DOX as of Q3 2021.

Central Bank & Trust reported no remaining Amdocs position as of Q3 2021 after selling out during the quarter.
Central Bank & Trust sold 550 Amdocs shares in Q3 2021, an estimated $43K.
Central Bank & Trust first reported a position in Amdocs in Q1 2021 and held it in 2 quarters.
Central Bank & Trust's Amdocs position peaked at $43K in Q2 2021.
411 funds tracked by Wall St. Rank held Amdocs as of Q3 2021.

Based on Central Bank & Trust's 13F filing for Q3 2021, filed 19 Oct 2021.